Skip to main content

Table 3 Comparison between patients with atrial fibrosis and those without atrial fibrosis

From: The use of MRI in quantification of the atrial fibrosis in patients with rheumatic mitral disease

  Patients with atrial fibrosis (n = 40) Patients without atrial fibrosis (n = 20) P value
Age, year 34.72 ± 8.11 28.40 ± 7.00 0.004
Gender, male 19 (54.5%) 3 (45.5%) 0.014
DM 5 (12.5%) 0 0.159
HTN 2 (5%) 0 0.548
CVS 1 (2.5%) 0 0.99
Duration of symptoms, month 29.55 ± 14.90 18.60 ± 7.76 0.003
Mitral valve area by echo, cm2 1.18 ± 0.162 1.38 ± 0.116 < 0.001
LA diameter by echo, cm 4.99 ± 0.537 4.46 ± 0.176 < 0.001
LA diameter/BSA, cm/m2 2.71 ± 0.315 2.40 ± 0.184 < 0.001
LA volume by echo, ml 75.60 ± 7.45 67.90 ± 5.45 < 0.001
LA volume index by echo, ml/m2 41.09 ± 4.37 37.07 ± 4.04 0.001
Atrial fibrillation 30 (75%) 0 < 0.001
  1. DM diabetes mellitus, HTN hypertension, CVS cerebrovascular stroke, BSA body surface area